(Q44946386)

7 December 2017

title

Conventional measures underestimate glycaemia in cystic fibrosis patients (English)

1 reference

7 December 2017

0 references

Dobson L

1

1 reference

7 December 2017

Sheldon CD

series ordinal

2

1 reference

7 December 2017

Hattersley AT

series ordinal

3

1 reference

7 December 2017

publication date

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

21

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

691-696

1 reference

Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Clinical improvement in cystic fibrosis with early insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Efficacy and reliability of the continuous glucose monitoring system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Glucose tolerance in patients with cystic fibrosis: five year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Glucose intolerance in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Pancreatic alpha and beta cell functions in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

Pancreatic endocrine function in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01219.X

10.1111/J.1464-5491.2004.01219.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference